Dr Marcel Doerflinger
Honorary (Fellow)
Department of Medical Biology (WEHI)
61 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Efferocytosis of apoptotic bodies drives SARS-CoV-2 infection and macrophage inflammation
DOI: 10.1038/s41467-026-74363-82026
Journal article
Immunophenotype and proviral landscape of HTLV-1c infection and pulmonary disease
DOI: 10.1016/j.ebiom.2026.1064032026
Journal article
Cas9-expressing HC-04 hepatocytes facilitate CRISPR-based analysis of Plasmodium falciparum sporozoite-host interactions
DOI: 10.1371/journal.pgen.10121372025
Journal article
Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection
DOI: 10.1038/s41467-025-65098-z2025
Journal article
Metabolic modeling elucidates phenformin and atpenin A5 as broad-spectrum antiviral drugs against RNA viruses
DOI: 10.1038/s42003-025-08148-y2025
Journal article
Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo
DOI: 10.1016/j.cell.2025.06.0232024
Research grants (ARC, NHMRC, MRFF)
Transforming Infection Management in the Era of Emerging Cancer Therapies
RECENT SCHOLARLY WORKS
2025
Journal article
Lipid nanoparticle-delivered intrabodies for inhibiting necroptosis and pyroptosis
DOI: 10.1042/bcj202531912025
Journal article
NLRP3 inflammasome–driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitors
DOI: 10.1126/sciadv.adv00792025
Journal article
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling
DOI: 10.1038/s41418-025-01459-x2025
Journal article
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID
DOI: 10.1038/s41467-025-57905-4